A recent study mapped the known association of type 1 diabetes with the cytotoxic T lymphocyte-associated antigen 4 gene to a polymorphism at the 3end (؉6230G>A), but could not rule out additional contribution from the 5 end of the gene. To examine this possibility, we analyzed four polymorphisms at the 5-flanking region for effects independent of ؉6230G>A. We confirm, by the transmission disequilibrium test, in 496 family trios overtransmission of the susceptibility allele (G) at ؉6230 (217/168; P ‫؍‬ 0.013). Of the four promoter polymorphisms, one (؊319C>T) showed overtransmission of the C allele (97/58; P ‫؍‬ 0.0017). Because the undertransmitted T at the promoter is in linkage disequilibrium with the overtransmitted G at ؉6230G>A, the effect observed at the promoter cannot be accounted for by linkage disequilibrium with the ؉6230G>A. We confirm this by showing that parents heterozygous at the promoter but homozygous at ؉6230 overtransmit the C promoter allele even more significantly (53/24; P ‫؍‬ 9 ؋ 10 ؊4 ). In vitro, the T promoter allele directs higher luciferase expression in Jurkat cells by 42% (P ‫؍‬ 0.006), a difference also found in lymphocyte mRNA from eight individuals heterozygous at the promoter, but homozygous at ؉6230 (P ‫؍‬ 1.3 ؋ 10 
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CTLA-4 is a critical T cell surface receptor, the lack of which results in uncontrolled T cell-mediated lymphoproliferative disease in the CTLA4 Ϫ/Ϫ mouse (26, 27) . CTLA-4 down-regulates the autoimmune response in experimental animal models (28 -32) , and blockade of CTLA-4 signaling in human cancer patients elicits autoimmune manifestations (33) ; its importance in immune regulation makes it a very strong functional candidate for association with autoimmune disease.
A recent study (7) defined the extent of the associated haplotype based on a case-control study of 840 Graves' disease patients and on TDT in 3600 T1D families as well as 210 Graves' disease families. It confirmed the previous finding (6) that the association is confined to CTLA4 and does not extend to neighboring genes. For both diseases, the strongest association was found at ϩ6230GϾA, a newly described, single nucleotide polymorphism (SNP) in the 3Ј-flanking region, downstream of the previously known polyadenylation site. This polymorphism may be associated with altered levels of steady state mRNA of a soluble CTLA4 isoform (sCTLA4) through a mechanism that remains unclear, but could involve allele-dependent differential alternative splicing and/or polyadenylation of sCTLA4. In Graves' disease, all of the association could be attributed to ϩ6230GϾA, whereas the more rigorous TDT test in 3600 T1D families failed to narrow the causative polymorphism exclusively to the 3Ј end, and effects from the 5Ј end could not be excluded (7) . The aim of this study was to dissect the contributions of the 5Ј and 3Ј ends of CTLA4 to T1D susceptibility with a combination of functional and genetic studies.
The T1D-associated CTLA4 haplotype contains several polymorphisms in tight linkage disequilibrium (LD), any one of which or a combination thereof could determine the functional effect (Fig. 1 ). Of these, the only nonsynonymous polymorphism is a ϩ49AϾG base substitution causing a Thr 17 Ala change in the signal peptide. We have recently shown that the predisposing Ala 17 allele is incompletely glycosylated in the endoplasmic reticulum leading to retrograde transport of a portion of the molecules to the cytoplasm for degradation (34) . This ultimately results in less mature CTLA-4 (Ala 17 ) at the cell surface, which may explain in part the reduced inhibitory function of CTLA-4 reported in individuals with the ϩ49G allele (35, 36) . There are also several promoter polymorphisms in the LD block that could contribute to the T1D association through transcriptional effects on expression, independently of and in addition to the effect of the 3Ј-flanking ϩ6230GϾA on splicing or RNA stability. In this study we have found that the most proximal promoter polymorphism, Ϫ319CϾT, is highly associated with T1D and that this association is independent of the effect of the 3Ј SNP ϩ6230GϾA. We also show through in vitro and in vivo studies, an allele-dependent effect of the promoter on CTLA4 transcription levels.
Subjects and Methods Subjects
Genomic DNA was obtained from 496 family trios, most of whom attended the diabetic clinic at the Montréal Children's Hospital. Ethnic backgrounds were mostly mixed European; the largest single group was Québec French-Canadian. All participants were diagnosed before the age of 18 yr and required insulin treatment continuously from the time of diagnosis. Informed consent was obtained for all individuals involved in this study, which was approved by the research ethics boards of the hospitals where recruitment took place.
Genotyping
The ϩ49AϾG signal peptide polymorphism was genotyped by restriction digest and/or TaqMan. For the manual genotyping, the forward primer, 5ЈATGGCTTGCCTTGGATTTCA-3Ј, and the reverse primer, 5Ј-CTTTGCAGAAGACAGGGATG-3Ј, were used to amplify a 110-bp fragment, followed by digestion by TseI (New England Biolabs, Beverley, MA). The products were resolved on 10% PAGE. For genotyping using TaqMan, the primers used for amplification were: forward, 5Ј-ATGGCTTGCCTT-GGATTT-3Ј; and reverse, 5Ј-GCAGAAGACAGGGATGAAGA-3Ј. The forward probe used was 5Ј-tetrachloro-6-carboxy-fluorescein-CCAGGTCCT-GGTAGCCAGGTTC9-tetramethylrhodamine-3Ј, and the reverse was 5Ј-6-carboxyfluorescein-AGGTCCTGGCAGCCAGGTTC9-tetramethylrhodamine-3Ј.
The Ϫ1722(TϾC), Ϫ1661(AϾG), Ϫ658(CϾT) and Ϫ319(CϾT) SNPs in the CTLA4 promoter and the ϩ6230(GϾA) SNP in the 3Ј end were genotyped using single nucleotide primer extension with dideoxy-NTPs labeled with different fluorochromes corresponding to each allele. Primer and probe sequences for fluorescence polarization (FP) are listed in Table 1 . Unincorporated PCR primers and deoxy-NTPs were removed according to the PE AcycloPrime PCR Clean-Up protocol, and primer extension was performed according to the PE AcycloPrime-FP protocol in a GeneAmp PCR system 9700 (MJ Research, Waltham, MA). Final detection of the SNP by FP used the Criterion System with Analyst HT (Molecular Devices, Sunnyvale, CA). The genotyping call rate was 97% or greater for all SNPs, and a Mendelian error rate of 0.001 was detected.
Statistics and data analysis
Functional data were compared with the two-tailed, paired t test. The paired test was used when comparing DNA and RNA from the same individual or in vitro expression of each allelic construct in each of the five experimental replications, to account for variation among experiments that affected both alleles equally.
The binomial distribution with P ϭ 0.05 under the null hypothesis FIG. 1. Summary of genetic and functional significance of SNPs within the CTLA4 gene. The Ϫ319 and ϩ49 SNPs lie within a highly conserved region (overall sequence homology among mouse, rat, and human, 79%). Evolutionary sequence conservation is the best a priori criterion for selecting regulatory sequences to evaluate the functional importance (43, 44) . The shaded area in the 5Ј end is the highly conserved promoter region (ϳ400 bp), which includes the Ϫ319 SNP, but not the Ϫ658 SNP. Potential functional roles are shown in boxes, and some are addressed in this study.
[ Figure 1 was used to evaluate the transmission disequilibrium test (TDT) data. The TDT is based on the distortion from the expected 50% transmission of alleles at a marker locus from heterozygous parents to affected children when the marker is both linked and associated with the disease (37) . Because of strong prior evidence, the ϩ6230G/A polymorphism was evaluated at an unadjusted ␣ level of 0.05. For multiple testing of the four promoter SNPs, the Bonferroni-adjusted ␣ level for each SNP was calculated as 1 Ϫ (1 Ϫ ␣) 1/n , where ␣ is the overall significance threshold (0.05). Thus, individual results were considered significant at P Յ 0.0127.
Genotype odds ratios were computed using pseudocontrols generated from the untransmitted parental alleles assuming Hardy-Weinberg equilibrium. For haplotype analysis including haplotype TDT, the Family-Based Association Test software was used (http://biostat. harvard.edu/ϳfbat/fbat.htm).
Promoter constructs
Genomic DNA from a heterozygote Ϫ319CϾT was used to amplify a 662-bp fragment of the CTLA4 promoter. The forward primer used was 5Ј-GCTGTCAAGGGACCATTAGAAGGA-3Ј, and the reverse primer was 5Ј-GGCTTTATGGGAGCGG TGTTG-3Ј. PCR product was T-cloned into pCR2.1 (Invitrogen Life Technologies, Carlsbad, CA). Clones representing each allele were screened by PCR and MseI (New England Biolabs) restriction digestion as previously described (38) . Clones were sequenced and ligated into pGL3-Basic at KpnI and XbaI sites (New England Biolabs). The constructs are denoted herein as pCTLAT Ϫ319 and pCTLAC Ϫ319 .
Transfections and luciferase reporter assays
Jurkat T cells were maintained in RPMI 1640 supplemented with 10% fetal bovine serum, 1 mm sodium pyruvate, 1 mm MEM, and 100 U/ml penicillin/streptomycin at 37 C in 5% CO 2 (cell culture reagents from Invitrogen Life Technologies). Cells (5 ϫ 10 5 ) were transfected in triplicate with 2 g CTLA4 promoter constructs and 10 ng of the transfection control Renilla luciferase, pRL-cytomegalovirus (Promega Corp., Madison, WI) using Lipofectamine 2000 according to the manufacturer's instructions. All transfections were performed with the same plasmid DNA Maxiprep preparation. The cells were activated with 1 g/ml phytohemagglutinin (PHA) and 50 ng/ml phorbol myristate acetate (PMA; Sigma-Aldrich Corp., St. Louis, MO) 4 h after transfection for 48 h. Although PHA and PMA are physiologically irrelevant stimuli, they were found to be specifically required for constitutive expression of Renilla-luciferase under control of the cytomegalovirus promoter in the Jurkat cell line (39) . Luciferase assay was performed using Promega's Dual Luciferase Reporter Assay following the manufacturer's instructions. The assay was performed on 96-well plates, with detection by a multisample, plate-reading luminometer (MicroLumat Plus; E&G Berthold, Bad Wildbad Germany).
DNA and RNA samples
Genomic DNA was extracted from whole blood by standard phenolchloroform methods. RNA from whole blood was extracted using a QIAamp RNA Blood Mini kit (Qiagen, Hilden, Germany). Peripheral blood mononuclear cells (PBMCs) were obtained from whole blood by standard Ficoll gradient, and 5-8 ϫ 10 6 cells were cultured in RPMI 1640 supplemented with 5% heat-inactivated fetal bovine serum, 1 mm sodium pyruvate, and 2 m ␤-mercaptoethanol and activated with 5 g/ml concanavalin (Sigma-Aldrich Corp.) and 10 nm PMA (SigmaAldrich Corp.) overnight. RNA was isolated from PBMCs using the RNeasy Mini Kit (Qiagen) with on-column deoxyribonuclease treatment.
PCR, RT-PCR, and quantification of allelic differences by dideoxy sequencing
RT was performed under standard conditions using random primers and 250-1000 ng total RNA template. Primers for exon 1 of CTLA4 (includes the ϩ49AϾG polymorphism) in DNA were: forward, 5Ј-AT-GGCTTGCCTTGGATTTCA-3Ј; and reverse, 5Ј-CTTTGCAGAAGA-CAGGGATG-3Ј. For RT-PCR an antisense primer, 5Ј-GCTGGGC-CACGTGCATTGCT-3Ј, spanning exons 1 and 2 was used. These All sequences are in the 5Ј-3Ј direction. All primers and probes were designed using primer3 software available online at: http://genome.wi.mit.edu/genome_software/oth-er/ primer3.html (46) . primers do not distinguish between the soluble and full-length splicing isoforms. PCR amplicons were purified by the QIAquick PCR Purification Kit (Qiagen) according to the manufacturer's instructions and were sequenced. Allele-specific quantification by sequencing was performed by comparing ratios of peak heights of each allele in a single reaction in matching RNA and DNA samples from heterozygous individuals amplified, respectively, by RT-PCR or PCR (Fig. 2B) . The peak height at a particular base is proportional to the amount present in the sample. This methodology has been validated previously (40) , but we tested the principle by mixing known quantities of PCR derived from genomic DNA of individuals homozygous for each allele and sequencing the mixtures. We used the ϩ49AϾG SNP as a proxy for the Ϫ319 and ϩ6230 SNPs due to the strong LD among the three loci (DЈ ϭ ϳ0.8); hence, a T allele at Ϫ319 is in LD with an A at ϩ49 and a G at ϩ6230, a haplotype that was also found by Johnson et al. (41) . All haplotypes of individuals used in the allelic imbalance studies were confirmed with genotypes of family members. The proportions of ϩ49A/A:ϩ49G/G mixed were 90:10, 70: 30, 50:50, 30:70, and 10:90 (Fig. 2B) . The observed ratios of A49 over G49 were plotted against the expected, and the correlation between observed and expected was strikingly good (r 2 ϭ 0.95 and 0.98 for A and G, respectively), thereby validating the method for allelic-specific quantification ( Fig. 2A) . Ratios of peak height corresponding to each allele in DNA samples ranged between 0.8 -1.2. In the corresponding RNA samples, an allelic imbalance was said to exist when this ratio deviated from the 0.8 -1.2 range. All RNA and DNA peak heights are reported as a ratio of (peak height at allele A)/(average peak height of three A bases upstream and three A bases downstream of ϩ49A) over (peak height at allele G)/(average peak height of three G bases upstream and three G bases downstream of ϩ49G). We refer to this ratio as a standardized ratio.
Results
Genetic studies: T1D association with the Ϫ319 promoter SNP cannot be accounted for by LD with the 3Ј ϩ6230 SNP The recent study by Ueda et al. (7) finds a strong association between a 3Ј-flanking SNP, ϩ6230GϾA, and Graves' disease that cannot be explained by another SNP in the haplotype, thus strongly implicating this SNP as the causative variant in CTLA4. However, in the same study the association with T1D was much weaker, and an effect at the 5Ј end cannot be ruled out (7) . To separate these effects on genetic grounds and narrow down the potential functional SNPs, we genotyped five SNPs contained within the CTLA4 haplotype block, previously defined as haplotype tag SNPs (htSNPs) (41) . htSNPs can be used to probe the haplotype diversity of an LD block without genotyping all polymorphisms within a block. In addition, we genotyped the ϩ6230GϾA 3Ј SNP in 496 diabetic family trios (Fig. 1) . We confirmed association of ϩ6230GϾA with T1D in our dataset. We found significant overtransmission of the ϩ6230G allele by TDT (217/168; P ϭ 0.013; Table 2 ). However, the transmission distortion was stronger in the promoter where the C allele was significantly overtransmitted (97/58; P ϭ 0.0017; Table 2 ). The Mendelian error rate for the Ϫ319CϾT polymorphism was 1/1100, and parental genotypes for both SNPs were in Hardy-Weinberg equilibrium. The odds ratios were 1.29 (95% confidence interval, 0.9 -1.73) for ϩ6230 (AA vs. AGϩGG) and 1.67 (95% confidence interval, 1.19 -2.39) for Ϫ319 (CC vs. CTϩTT). The other three SNPs examined in the CTLA4 5Ј-flanking region were not associated with T1D (Table 2), and the ϩ49AϾG was associated with T1D in our dataset as reported in multiple studies (8, 9, 11, 12) , probably through its LD with the ϩ6230GϾA, as proposed by Ueda et al. (7) .
To explore the full haplotype diversity at CTLA4, we genotyped the previously reported htSNPs (41) required to define the five haplotypes that represent 97% of European chromosomes. On haplotype-based TDT analysis, only one haplotype was significantly overtransmitted after correction for multiple tests, and it contained C at Ϫ319 and G at ϩ6230G (P ϭ 0.0021; Table 3 ). Two-SNP TDT analysis on the promoter (Ϫ319CϾT) and 3ЈSNP (ϩ6230GϾA) revealed significant overtransmission of the Ϫ319C;ϩ6230G haplotype (P ϭ 0.00028; Table 4 ).
Examination of the haplotype frequencies suggested that the ϩ6230GϾA (which accounts for all other previously reported CTLA4-T1D associations) (7) cannot account for the transmission distortion at Ϫ319, because the overtransmitted G allele at ϩ6230 was in near-perfect LD (DЈ ϭ 0.96) with the undertransmitted Ϫ319 T allele (41) (confirmed in our dataset). The independence of the transmission distortion at Ϫ319 from the ϩ6230 effect is more directly demonstrated by conditional TDT analysis, by which transmissions from parents heterozygous at one locus, but homozygous at the other, FIG. 2 . Allelic imbalance in the RNA is quantified by sequencing. To quantify differential expression of the two alleles, the RT-PCR product is sequenced, and the ratio of the peak heights of the two allelic bases is used to estimate relative abundance in steady state mRNA. A, The method was validated by sequencing mixtures, in defined proportions, of PCR product derived from homozygotes for each ϩ49 allele. The observed relative amount of each allele is plotted against the known amount. (The dashed line is the ϩ49A allele, and the solid line is the ϩ49G allele). The observed values in the sequencing results correlate strikingly well with those expected from the mixture. B, The peak height at the SNP is proportional to the amount sample (40) (black chromatogram, ϩ49A; gray, ϩ49G). Each value at the SNP base peak is corrected by dividing it by the average peak height of adjacent identical bases defined throughout the text as standardized. This accounts for variations within individual sequencing reactions independent of the relative amount of allele. Although peak heights for the same base vary within the same sequence, the nucleotide peak in any given position in relation to its same-base neighbors is remarkably stable across samples run in the same sequencing reaction.
were counted. We first examined only transmissions from parents who were homozygous at ϩ6230, but were heterozygous at the promoter locus (Ϫ319; Ϫ319T;ϩ6230G vs. Ϫ319C; ϩ6230G and the very few Ϫ319T;ϩ6230A vs. Ϫ319C;ϩ6230A parents), thereby eliminating any effect the 3Ј-flanking SNP may have on the probability of transmission. In this group, the C allele remained significantly overtransmitted (53/27; P ϭ 9 ϫ 10 Ϫ4 ; Table 5 ). Similarly, in parents heterozygous at ϩ6230, but homozygous at Ϫ319, the G allele at ϩ6230 was still significantly overtransmitted (145/99; P ϭ 0.003; Table  5 ). In fact, removal of the Ϫ319 T effect strengthens the association at ϩ6230 (P ϭ 0.013 with the promoter vs. P ϭ 0.003 despite the smaller number).
The simplest explanation for this observation is that neither of the two SNPs is responsible for the functional effect, but that the C and G alleles mark a haplotype that contains an as yet unexamined functional polymorphism. Alternatively, both polymorphisms function independently of each other. Ueda et al. (7) present both functional and genetic evidence in favor of ϩ6230 being the functional variant. To search for a possible mechanism underlying a contribution of the Ϫ319CϾT promoter SNP under the second hypothesis, we examined its effects on CTLA4 transcription. The following sections address these issues.
Functional studies
Proximal CTLA4 promoter region is highly conserved, and the Ϫ319C allele is part of the lymphoid enhancer factor-1 (LEF1) transcription consensus site. The SNPs upstream of Ϫ319 were not associated with T1D in our population (Table 2 ), but it is still possible that an unknown SNP in LD with Ϫ319CϾT might be responsible for the independent genetic effect. Unlike coding sequences, the bounds of promoter-enhancer regions are not clearly defined. In genes such as CTLA4, with Association with T1D was tested using haplo-FBAT software. The LD block containing the entire CTLA4 gene can be represented by five common haplotypes (frequency, Ͼ5%), which account for more than 97% of all chromosomes observed.
a The Ϫ1722 htSNP was not included in this analysis because it is redundant with the ϩ49AϾG htSNP as reported previously (41) (confirmed in our own dataset, such that a T allele at Ϫ1722 appears exclusively on ϩ49G chromosome, and both DЈ and r 2 values are ϳ1). We chose the ϩ49 SNP due to its higher heterozygosity rate.
b The z-score is positive when the haplotype is overtransmitted and negative when undertransmitted. c Not significant. The P value was calculated by a two-tailed, binomial distribution test.
a TDT performed on heterozygous parents at Ϫ319, who were homozygous at ϩ6230.
b TDT performed on ϩ6230GϾA heterozygous parents who were homozygous at Ϫ319.
highly conserved structure and function (42) , evolutionary sequence conservation is a good indicator of functional importance (43, 44) . Comparative sequence analysis among mouse, rat, and human, showed that the Ϫ319CϾT SNP lies within a 400-bp region of high conservation (overall similarity, 79%), directly upstream of the ϩ1 transcriptional start site (Fig. 1) . This sequence completely encompasses the 335-bp promoter shown by Lindsten et al. (45) to be sufficient for regulated in vitro expression of CTLA4. None of the other 5Ј-flanking SNPs mapped to a highly conserved sequence.
In addition, we analyzed whether any of the promoter SNPs altered transcription factor (TF) binding sites by submitting 20 -30 bases flanking each SNP to MatInspector (http:// genomatix.de/cgi-bin/matinspector_prof/mat_fam.pl) (46) . Two potential TF elements were detected, although only one mapped to a phylogenetically conserved region, the LEF1 that binds the consensus sequence Ϫ317 ttCAAAG Ϫ322 (Ϫ319 C is in bold, the core sequence is underlined, and the TF consensus sequence is in uppercase). The Ϫ319T allele did not correspond to the binding element of any known transcription factor. Although SNP Ϫ1661 also modified an MEF2 response element, it lies outside the 5Ј-conserved region and is not associated with T1D. Based on these data, we chose to focus our efforts on the promoter SNP most likely to play a functional role in regulation, the Ϫ319CϾT SNP.
Transcriptional effects of the Ϫ319T allele at the CTLA4 promoter.
We investigated the effect of the C to T base change in the promoter of CTLA4 by testing its ability to drive the expression of the luciferase reporter gene. Constructs containing 662 bp of the CTLA4 promoter region including the SNP at Ϫ319 bp were expressed in the Jurkat T cell line. The expression of luciferase was inducible in Jurkat cells by the addition of PHA and PMA and was standardized against the transfection control plasmid Renilla, pRL. The results are depicted in Fig. 3 and are expressed as relative luciferase units (luciferase/pRL ϫ 100). There was no detectable difference between pCTLA-T Ϫ319 and pCTLA-C Ϫ319 in Jurkat cells when not activated. Upon activation by PHA and PMA, luciferase expression increased by 3-and 4-fold for pCTLA-C Ϫ319 and pCTLA-T Ϫ319 , respectively (Fig. 3) . The relative luciferase levels were significantly higher in pCTLA-T
Ϫ319
transfections than pCTLA-C Ϫ319 (21.8 Ϯ 2.27 vs. 15.8 Ϯ 2.05; P ϭ 0.005, by paired t test; n ϭ 5). All transfections were performed in triplicate, and the results shown are the means of five independent experiments. These results confirm a previous report in which greater luciferase expression was found in constructs containing the T allele in the promoter (47) . We confirm similar allelic differences in a larger genomic context (662 bp of the promoter vs. 329 bp). The next section confirms that the differential transcriptional regulation of CTLA4 promoter alleles in vitro was reproducible in human lymphocytes in vivo.
The Ϫ319 T allele of the CTLA4 promoter is associated with greater expression in human lymphocytes
To determine whether this in vitro effect reflects in vivo transcription, individuals heterozygous at the promoter Ϫ319 (C/T) and at the signal peptide ϩ49 (A/G) were selected (n ϭ 8). Due to tight LD, the haplotypes in the vast majority of such individuals are Ϫ319T;ϩ49A;ϩ6230G/-319C;ϩ49G;ϩ6230G, allowing us to use the transcribed ϩ49AϾG polymorphism to distinguish transcripts derived from the two promoter alleles. This was confirmed in each individual by examining genotypes of family members. We quantified relative mRNA expression levels by comparing the ratio of ϩ49 A/G in RNA with that of the corresponding ϩ49 A/G DNA ratio. This was accomplished by sequencing an RT-PCR product (as described in Subjects and Methods and Fig. 2 ). When steady state RNA levels of ϩ49A and ϩ49G were compared within the same individuals, statistically significant higher expression was detected from the Ϫ319 T;ϩ49A;ϩ6230G haplotype in activated PBMCs [0.39 Ϯ 0.006 vs. 0.29 Ϯ 0.005 (mean Ϯ sem) for ϩ49A and ϩ49G, respectively; P ϭ 3.34 ϫ 10 Ϫ9 , by paired t test; Fig. 4A , lower graph]. A similar difference was detected in activated PBMCs and is depicted in Fig. 4 (0.39 Ϯ 0.004 vs. 0.29 Ϯ 0.012 for ϩ49A and ϩ49G, respectively; P ϭ 1.3 ϫ 10 Ϫ4 , by paired t test), almost precisely mirroring the in vitro effect shown in the previous section. Whereas the ϩ49 A/G ratio in DNA was 1.01 Ϯ 0.021 (Ϯsem) in the RNA of activated PBMCs, it was 1.32 Ϯ 0.05 and 1.36 Ϯ 0.02 in inactivated cells, clearly indicating increased transcription from the Ϫ319T;ϩ49A;ϩ6230G haplotype. Because of the LDs described above, all Ϫ319CϾT and 49AϾG heterozygous individuals examined in this study were G/G homozygous at the 6230 3Ј polymorphism; therefore, these results cannot be attributed to possible effects of 6230 on the soluble isoform.
Discussion
Due to the haplotype structure of the human genome, determination of the polymorphism(s) responsible for genetic association of a haplotype with a phenotypic trait must often rely on complementing genetic studies with functional ones. Ultimately, however, the only way to distinguish between independent functional effects of the Ϫ319 and ϩ6230 SNPs vs. the functional effect of some other polymorphism for which they are merely markers can be performed only by systematic association studies of all polymorphisms in the LD block. This was actually done by Ueda et al. (7) in their Graves' disease dataset and failed to identify a polymorphism with an effect stronger than that of ϩ6230 after a resequencing effort that is unlikely to have missed an SNP responsible for the effect (7, 41) . The alternative explanation is that Ϫ319CϾT polymorphism has an independent functional effect. Both the genetic and the functional effects described in Results are independent of LD with the 3Ј-flanking SNP, because both were observed in individuals homozygous at ϩ6230. In this study we confirm the approximately 30% increase in expression at the Ϫ319 T allele described in previous in vitro studies and directly demonstrate that this expression difference is reproducible in human lymphocytes, the cells involved in diabetes autoimmunity. It is conceivable that a single base substitution in a critical region for transcription factor binding, such as that of the LEF1 factor, may affect transcriptional efficiency, the regulation of which is an important determinant in the pathogenesis of disease. Such is the case for the TNF promoter, where allelic-specific binding of the transcription factor OCT1 determines survival outcome in malaria infections (48) .
A study comparing lymphocyte expression levels in 44 individuals heterozygous at the promoter vs. 186 homozygotes (C/C) found an effect in a small number of myasthenia gravis patients, but not in normal controls or in patients with multiple sclerosis (49) . This inconsistent result is not surprising, because between-individual comparisons may easily miss subtle differences in the noise introduced by intersubject variation due to genetic loci in trans and the individual's immune and other environmental experience. Our approach solves the problem by eliminating biological (as opposed to technical) noise by comparing transcriptional effects within the same cell sample from the same heterozygous individual and is becoming the standard for evaluating the subtle transcriptional effects responsible for complex phenotypes (50, 51) .
The assumption that a disease marker association must be reduced to LD with a single functional polymorphism is often implicit in discussions of complex traits, but under the common variant/common disease hypothesis, it is quite plausible that more than one SNP may be contributing functional effects, which, each in isolation, might not have been substantial enough to detect. Ueda et al. (7) addressed this possibility and, in the case of T1D, could not rule out an effect from the 5Ј end of CTLA4. They did not, however, examine the Ϫ319CϾT polymorphism.
The possibility of two independent effects at the CTLA4 locus suggests yet another complexity that must be considered when dissecting association haplotypes. In the presence of two functional polymorphisms on the same LD block, it is possible that the predisposing allele of one is in LD with the protective allele of the other, in which case the genetic effects of individual SNPs will be blunted by an increase in the frequency of haplotypes that carry one predisposing and one protective allele. In the case of CTLA4, under the twoeffect hypothesis, the predisposing CG haplotype exerts its genetic effect against a background of partially predisposing haplotypes TG and CA, because the nonpredisposing TA is virtually absent because of the LD. This diminishes the genetic effect of each SNP examined separately.
Although Ϫ319CϾT appears to confer higher risk than ϩ6230GϾA (odds ratio, 1.67 vs. 1.29, respectively), it is overshadowed in the haplotype association because of the low frequency of the minor T allele. Nevertheless, for individuals carrying that allele, it must be taken into account in any future algorithms used to determine T1D risk from a panel of genotypes.
The recent association of the ϩ6230GϾA 3Ј flanking SNP with Graves' disease and T1D reported in the largest and most comprehensive SNP mapping and association study to date raises some important issues (7). The researchers found increased susceptibility to autoimmune disease associated with the ϩ6230 G allele. They propose that the predisposing ϩ6230 G allele mediates the lower expression of a soluble CTLA4 isoform, sCTLA4. A molecular mechanism to explain such effects remains unclear. Although Ueda et al. (7) show evidence of the presence of the 3ЈSNP in Northern blot transcripts, no clear molecular model was proposed. If an alternative polyadenylation site indeed exists that includes ϩ6230GϾA in the mRNA, this SNP might affect RNA stability and/or the efficiency of the alternative splicing that creates sCTLA4. The possibility of an effect through a 3Ј enhancer cannot be eliminated either, because we are not aware of any conclusive evidence that sCTLA4 is transcribed from the same promoter as the full-length form.
Ueda et al. (7) reported highest association in the 3ЈUTR of CTLA4 with Graves' disease and autoimmune thyroiditis after testing 108 SNPs. They subsequently tested only nine FIG. 4 . Allelic imbalance at the CTLA4 promoter locus in human lymphocytes ex vivo correlates with in vitro data; the Ϫ319 T promoter allele induces higher CTLA4 mRNA levels. PBMCs from individuals heterozygous at the Ϫ319 locus and the ϩ49 locus were used to assess allelic variation at the promoter (Fig. 2 and Subjects and Methods) There is consistently higher RNA levels due to the T alleles than the C alleles (P ϭ 1.3 ϫ 10
Ϫ4
; n ϭ 8) in inactivated PBMCs. Similar data are obtained in activated PBMCs. Each data point represents an average of at least two independent experiments per individual, and the lines connect data for each individual.
SNPs in the 3600 T1D families, not including the Ϫ319 promoter SNP. Its effect partially explains the weaker association they found in the 3Ј end (odds ratio, 1.15). Our data clearly point to independent effects of the promoter and the 3Ј end. After accounting for the promoter SNP, the odds ratio at 3Ј becomes substantially stronger. It is worth noting that Ueda et al. (7) found no association with the Ϫ319CϾT in Graves' disease, a disorder of humoral immunity whose pathogenesis is probably quite different from the T cellmediated destruction of the ␤-cells involved in T1D. If the role of the soluble form is more important in humoral immune dysregulation, it may overshadow the promoter effect. This scenario also provides an attractive explanation for the much weaker effect of ϩ6230GϾA in T1D than in Graves' disease (7) .
As in all disease association studies with candidate polymorphisms, our findings will need to be replicated in independent DNA sets. A poor reproducibility record in association reports is the result of multiple hypothesis testing without statistical correction. Unlike those reports, this study focused on only four SNPs after genetic evidence of an effect from the 5Ј end of the gene in addition to the 3Ј end.
To summarize, taken together with previous work, the results presented here raise the possibility of a model in which disease susceptibility is modulated through nonmutually exclusive, allele-specific transcriptional and, possibly, posttranslational mechanisms. These new, Homosapien-specific alleles may have arisen in evolution because of the need for better protection of humans against infection, an advantage that would have easily counterbalanced a small increase in the risk of autoimmunity.
